dopaminergic signaling pathway
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biological pathway
|
| gptkbp:dysregulationAssociatedWith |
gptkb:Parkinson's_disease
gptkb:depression addiction schizophrenia |
| gptkbp:foundIn |
central nervous system
|
| https://www.w3.org/2000/01/rdf-schema#label |
dopaminergic signaling pathway
|
| gptkbp:includes |
gptkb:mesolimbic_pathway
gptkb:mesocortical_pathway nigrostriatal pathway tuberoinfundibular pathway |
| gptkbp:involves |
dopamine
dopamine receptor |
| gptkbp:modulatedBy |
gptkb:monoamine_oxidase
gptkb:dopamine_transporter catechol-O-methyltransferase |
| gptkbp:regulates |
cognition
motivation motor control reward processing endocrine signaling |
| gptkbp:target |
gptkb:psychostimulants
antipsychotic drugs dopamine agonists dopamine antagonists |
| gptkbp:bfsParent |
gptkb:dopamine_receptor_D5
|
| gptkbp:bfsLayer |
7
|